Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
BMC Health Services Research|November 14, 2021
Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction databaseTuhin Maity, Christopher LongoVascular and Endovascular Surgery|May 28, 2005
Abdominal aortic aneurysm screening: recommendations and controversiesChristopher Longo, Gilbert R UpchurchJAMA Network Open|December 22, 2022
Longitudinal Assessment of Labor Market Earnings Among Patients Diagnosed With Cancer in CanadaYoung Jung, Christopher Longo, Emile TompaCanadian Journal of Public Health = Revue Canadienne De Sante Publique|February 12, 2022
Is vaccine hesitancy justified? Benchmarking post-market vaccine risks with five commonly used medicinal products in CanadaTuhin Maity, Ahmad von Schlegell, Christopher LongoHealthcare Policy = Politiques De Sante|June 16, 2017
Public Health Policy in Support of Insurance Coverage for Smoking Cessation TreatmentsRobert Schwartz, Farzana Haji, Alexey Babayan, et al.Journal of Occupational and Environmental Medicine|December 23, 2017
The Economic Burden of Bladder Cancer Due to Occupational ExposureYoung Long Jung, Emile Tompa, Christopher Longo, et al.Healthcare (Basel, Switzerland)|September 30, 2020
Translation and Cultural Adaptation of the Patient Self-Administered Financial Effects (P-SAFE) Questionnaire to Assess the Financial Burden of Cancer in French-Speaking PatientsDominique Tremblay, Thomas G Poder, Helen-Maria Vasiliadis, et al.Journal of Cancer Survivorship : Research and Practice|August 29, 2023
The association of cancer-related fatigue on the social, vocational and healthcare-related dimensions of cancer survivorshipJennifer M Jones, Doris Howell, Christopher Longo, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and functionShane T Grey, Christopher Longo, Tala Shukri, et al.Hepatology (Baltimore, Md.)|March 1, 2002
A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitisMaria B Arvelo, Jeffrey T Cooper, Christopher Longo, et al.Pageof 2